
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6658908
[patent_doc_number] => 20030134266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Methods of screening for compounds that modulate blood vessel formation'
[patent_app_type] => new
[patent_app_number] => 10/227192
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13047
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10227192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/227192 | Methods of screening for compounds that modulate blood vessel formation | Aug 21, 2002 | Abandoned |
Array
(
[id] => 8328391
[patent_doc_number] => 08236487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Tumor specific oligosaccharide sequences and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/487203
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12477
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10487203
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487203 | Tumor specific oligosaccharide sequences and use thereof | Aug 19, 2002 | Issued |
Array
(
[id] => 6696721
[patent_doc_number] => 20030108915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Glioblastoma multiforme associated protein GliTEN'
[patent_app_type] => new
[patent_app_number] => 10/224624
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10593
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108915.pdf
[firstpage_image] =>[orig_patent_app_number] => 10224624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/224624 | Glioblastoma multiforme associated protein GliTEN | Aug 19, 2002 | Abandoned |
Array
(
[id] => 256507
[patent_doc_number] => 07576182
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-08-18
[patent_title] => 'Compositions and methods for the treatment of immune related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/213042
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 40319
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/576/07576182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213042
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213042 | Compositions and methods for the treatment of immune related diseases | Aug 4, 2002 | Issued |
Array
(
[id] => 411760
[patent_doc_number] => 07282562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-16
[patent_title] => 'Compositions and methods for the treatment of immune related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/213145
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 41085
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/282/07282562.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213145
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213145 | Compositions and methods for the treatment of immune related diseases | Aug 4, 2002 | Issued |
Array
(
[id] => 849290
[patent_doc_number] => 07381809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-03
[patent_title] => 'Compositions and methods for the treatment of immune related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/213199
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 41089
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/381/07381809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213199 | Compositions and methods for the treatment of immune related diseases | Aug 4, 2002 | Issued |
Array
(
[id] => 7060998
[patent_doc_number] => 20050003359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Screening methods and sequences relating thereto'
[patent_app_type] => utility
[patent_app_number] => 10/485999
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10025
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003359.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485999 | Screening methods and sequences relating thereto | Aug 1, 2002 | Issued |
Array
(
[id] => 7169524
[patent_doc_number] => 20050202431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery'
[patent_app_type] => utility
[patent_app_number] => 10/509738
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 13195
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202431.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509738 | Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery | Jul 25, 2002 | Abandoned |
Array
(
[id] => 7116255
[patent_doc_number] => 20050069556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Identification of specific tumor antigens by means of the selection of cdna libraries with sera and the use of said antigena in the treatment of tumors'
[patent_app_type] => utility
[patent_app_number] => 10/484800
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6654
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484800 | Identification of specific tumor antigens by means of the selection of cdna libraries with sera and the use of said antigena in the treatment of tumors | Jul 24, 2002 | Abandoned |
Array
(
[id] => 6865213
[patent_doc_number] => 20030190739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Tankyrase2 materials and methods'
[patent_app_type] => new
[patent_app_number] => 10/199937
[patent_app_country] => US
[patent_app_date] => 2002-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35166
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199937
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199937 | Tankyrase2 materials and methods | Jul 21, 2002 | Abandoned |
Array
(
[id] => 224806
[patent_doc_number] => 07604989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-20
[patent_title] => 'Inhibition of apoptosis process and improvement of cell performance'
[patent_app_type] => utility
[patent_app_number] => 10/191052
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 47
[patent_no_of_words] => 10259
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/604/07604989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10191052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/191052 | Inhibition of apoptosis process and improvement of cell performance | Jul 9, 2002 | Issued |
Array
(
[id] => 6905508
[patent_doc_number] => 20050100903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Screening method'
[patent_app_type] => utility
[patent_app_number] => 10/482107
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8229
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100903.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482107 | Screening method | Jun 27, 2002 | Abandoned |
Array
(
[id] => 6846952
[patent_doc_number] => 20030166119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/175744
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166119.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175744 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 18, 2002 | Abandoned |
Array
(
[id] => 6944783
[patent_doc_number] => 20050196832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/175749
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 56391
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10175749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175749 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 18, 2002 | Abandoned |
Array
(
[id] => 6952134
[patent_doc_number] => 20050227228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Map3ks as modifiers of the p53 pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/479871
[patent_app_country] => US
[patent_app_date] => 2002-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13923
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479871 | Map3ks as modifiers of the p53 pathway and methods of use | Jun 2, 2002 | Abandoned |
Array
(
[id] => 6755271
[patent_doc_number] => 20030003048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Diagnostic imaging compositions, their methods of synthesis and use'
[patent_app_type] => new
[patent_app_number] => 10/126216
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21047
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126216 | Diagnostic imaging compositions, their methods of synthesis and use | Apr 18, 2002 | Abandoned |
Array
(
[id] => 6323961
[patent_doc_number] => 20020197261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use'
[patent_app_type] => new
[patent_app_number] => 10/126369
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10470
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126369
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126369 | Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use | Apr 18, 2002 | Abandoned |
Array
(
[id] => 7403244
[patent_doc_number] => 20040023860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Methods and compositions for inhibiting neoplastic cell growth'
[patent_app_type] => new
[patent_app_number] => 10/121034
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87930
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121034 | Methods and compositions for inhibiting neoplastic cell growth | Apr 9, 2002 | Issued |
Array
(
[id] => 7403244
[patent_doc_number] => 20040023860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Methods and compositions for inhibiting neoplastic cell growth'
[patent_app_type] => new
[patent_app_number] => 10/121034
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87930
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121034 | Methods and compositions for inhibiting neoplastic cell growth | Apr 9, 2002 | Issued |
Array
(
[id] => 5552751
[patent_doc_number] => 20090286737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'ERBB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 10/119288
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28241
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286737.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119288 | ErbB interface peptidomimetics and methods of use thereof | Apr 7, 2002 | Issued |